▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2878 by analyst upside · 2026-11-12
UTHR
United Therapeutics Corporation
Healthcare · Market Cap $25B · P/E 22.5x
ANALYST PRICE TARGET
+15.4%
implied upside to consensus target
Current Price $595.66
Consensus Target $687.14
Bull Target $850.0
Bear Target $390.0
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
8
Hold
2
Sell
1
52-Week Low $452.44
52-Week High $614.23
YTD Return +19.9%
FUNDAMENTALS
Market Cap $25B
P/E Ratio (TTM) 22.5x
Forward P/E 16.8x
EPS (TTM) $26.49
PEG Ratio 2.22
Dividend Yield N/A
Revenue (TTM) $3.2B
Profit Margin 38.6%
52-WEEK RANGE
52-Week Low $452.44
52-Week High $614.23
Current Price $595.66
Bear Target $390.0
Bull Target $850.0
● Now $595.66 ● Target $687.14
TRADING DATA
Avg Volume 704K
YTD Return +19.9%
Analyst Count 14
Consensus Buy
Upside to Target +15.4%
Last Updated 2026-11-12

ANALYST SUMMARY

United Therapeutics Corporation (UTHR) is currently trading at $595.66 with a Wall Street consensus price target of $687.14, implying potential upside of 15.4% over the next 12 months. 14 analysts currently cover UTHR, with a consensus rating of Buy - 79% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $850.0, while the most cautious has a target of $390.0.

UTHR operates in the Healthcare sector with a market capitalisation of $25B. The stock is up 19.9% year-to-date and is currently trading near the upper end of its 52-week range of $452.44 – $614.23.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

STE +5.6%
STERIS plc
$25B · P/E 30.5x · Buy
ZBH +8.2%
Zimmer Biomet Holdings, Inc.
$20B · P/E 27.1x · Hold
THC +4.5%
Tenet Healthcare Corporation
$23B · P/E 8.5x · Buy
DGX -0.6%
Quest Diagnostics Incorporated
$29B · P/E 25.8x · Buy
LH +4.8%
Labcorp Holdings Inc.
$30B · P/E 30.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for UTHR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

TD Cowen - Reiterated
Buy → Buy 2026-11-05 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-11-05 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-11-05 Building track record
BTIG - Reiterated
Buy → Buy 2026-11-04 38% win rate (8 calls)
JP Morgan - Reiterated
Overweight → Overweight 2026-10-28 43% win rate (7 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-10-22 Building track record
Leerink Partners - Reiterated
Outperform → Outperform 2026-10-19 29% win rate (7 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-10-08 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
50
out of 100
Coverage depth
21/30
Consensus clarity
15/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →